Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice

BACKGROUND: Impaired wound healing in diabetes is related to decreased production of growth factors. Hence, gene therapy is considered as promising treatment modality. So far, efforts concentrated on single gene therapy with particular emphasis on vascular endothelial growth factor-A (VEGF-A). Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Jazwa, Agnieszka, Kucharzewska, Paulina, Leja, Justyna, Zagorska, Anna, Sierpniowska, Aleksandra, Stepniewski, Jacek, Kozakowska, Magdalena, Taha, Hevidar, Ochiya, Takahiro, Derlacz, Rafal, Vahakangas, Elisa, Yla-Herttuala, Seppo, Jozkowicz, Alicja, Dulak, Jozef
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939607/
https://www.ncbi.nlm.nih.gov/pubmed/20804557
http://dx.doi.org/10.1186/1479-0556-8-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939607/
https://www.ncbi.nlm.nih.gov/pubmed/20804557
http://dx.doi.org/10.1186/1479-0556-8-6

Ejemplares similares